RECRUITING

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

Description

The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).

Study Overview

Study Details

Study overview

The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).

Patient Centered Education About Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy: a Pilot Randomized Controlled Trial

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

Condition
BRCA1 Mutation
Intervention / Treatment

-

Contacts and Locations

Durham

Duke University Health System, Durham, North Carolina, United States, 27710

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * BRCA1 or BRCA2 germline mutation
  • * scheduled for a risk-reducing salpingo-oophorectomy (RRSO) by Duke Gynecologic Oncologist
  • * premenopausal
  • * personal history of cancer
  • * postmenopausal
  • * \>50 years old
  • * unable to provide informed consent in English

Ages Eligible for Study

19 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Duke University,

Laura Havrilesky, PRINCIPAL_INVESTIGATOR, Duke University

Study Record Dates

2026-12-31